vs
AMN HEALTHCARE SERVICES INC（AMN）とEPLUS INC（PLUS）の財務データ比較。上の社名をクリックして会社を切り替えられます
AMN HEALTHCARE SERVICES INCの直近四半期売上が大きい（$748.2M vs $614.8M、EPLUS INCの約1.2倍）。EPLUS INCの純利益率が高く（5.7% vs -1.0%、差は6.7%）。EPLUS INCの前年同期比売上増加率が高い（20.3% vs 1.8%）。過去8四半期でEPLUS INCの売上複合成長率が高い（2.3% vs -4.5%）
AMNヘルスケアサービス社は米国の代表的な医療人材ソリューション企業で、病院・診療所などの医療機関に対し看護師、医師、医療技術者をはじめ臨床・非臨床スタッフの雇用紹介を行うほか、人材管理支援やコンサルティングサービスも提供している。
ePlus Inc.は米国発のコンサルティング型テクノロジーソリューションプロバイダーで、サイバーセキュリティ、クラウド、ネットワーク、コラボレーション、人工知能などの先進技術分野にわたり、5000社以上の顧客にソリューション、アドバイザリー、マネージドサービスを提供しています。
AMN vs PLUS — 直接比較
売上が大きい
AMN
1.2倍大きい
$614.8M
売上成長率が高い
PLUS
+18.5%の差
1.8%
純利益率が高い
PLUS
純利益率が6.7%高い
-1.0%
2年売上CAGRが高い
PLUS
2年複合成長率
-4.5%
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $748.2M | $614.8M |
| 純利益 | $-7.7M | $35.1M |
| 粗利率 | 26.1% | 25.8% |
| 営業利益率 | 1.1% | 7.1% |
| 純利益率 | -1.0% | 5.7% |
| 売上前年比 | 1.8% | 20.3% |
| 純利益前年比 | 95.9% | 45.2% |
| EPS（希薄化後） | $-0.19 | $1.33 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上AMNPLUS
| Q4 25 | $748.2M | $614.8M | ||
| Q3 25 | $634.5M | $608.8M | ||
| Q2 25 | $658.2M | $637.3M | ||
| Q1 25 | $689.5M | — | ||
| Q4 24 | $734.7M | $493.2M | ||
| Q3 24 | $687.5M | $493.4M | ||
| Q2 24 | $740.7M | $535.7M | ||
| Q1 24 | $820.9M | — |
純利益AMNPLUS
| Q4 25 | $-7.7M | $35.1M | ||
| Q3 25 | $29.3M | $34.9M | ||
| Q2 25 | $-116.2M | $37.7M | ||
| Q1 25 | $-1.1M | — | ||
| Q4 24 | $-187.5M | $24.1M | ||
| Q3 24 | $7.0M | $31.3M | ||
| Q2 24 | $16.2M | $27.3M | ||
| Q1 24 | $17.3M | — |
粗利率AMNPLUS
| Q4 25 | 26.1% | 25.8% | ||
| Q3 25 | 29.1% | 26.6% | ||
| Q2 25 | 29.8% | 23.3% | ||
| Q1 25 | 28.7% | — | ||
| Q4 24 | 29.8% | 25.4% | ||
| Q3 24 | 31.0% | 25.8% | ||
| Q2 24 | 31.0% | 23.7% | ||
| Q1 24 | 31.4% | — |
営業利益率AMNPLUS
| Q4 25 | 1.1% | 7.1% | ||
| Q3 25 | 7.5% | 8.0% | ||
| Q2 25 | -18.8% | 5.7% | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | -27.6% | 3.3% | ||
| Q3 24 | 3.2% | 5.5% | ||
| Q2 24 | 5.1% | 5.9% | ||
| Q1 24 | 4.9% | — |
純利益率AMNPLUS
| Q4 25 | -1.0% | 5.7% | ||
| Q3 25 | 4.6% | 5.7% | ||
| Q2 25 | -17.7% | 5.9% | ||
| Q1 25 | -0.2% | — | ||
| Q4 24 | -25.5% | 4.9% | ||
| Q3 24 | 1.0% | 6.3% | ||
| Q2 24 | 2.2% | 5.1% | ||
| Q1 24 | 2.1% | — |
EPS（希薄化後）AMNPLUS
| Q4 25 | $-0.19 | $1.33 | ||
| Q3 25 | $0.76 | $1.32 | ||
| Q2 25 | $-3.02 | $1.43 | ||
| Q1 25 | $-0.03 | — | ||
| Q4 24 | $-4.90 | $0.91 | ||
| Q3 24 | $0.18 | $1.17 | ||
| Q2 24 | $0.42 | $1.02 | ||
| Q1 24 | $0.45 | — |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $34.0M | $326.3M |
| 総負債低いほど良い | $767.1M | — |
| 株主資本純資産 | $642.1M | $1.1B |
| 総資産 | $2.1B | $1.8B |
| 負債/資本比率低いほどレバレッジが低い | 1.19× | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資AMNPLUS
| Q4 25 | $34.0M | $326.3M | ||
| Q3 25 | $52.6M | $402.2M | ||
| Q2 25 | $41.5M | $480.2M | ||
| Q1 25 | $55.8M | — | ||
| Q4 24 | $10.6M | $253.1M | ||
| Q3 24 | $30.6M | $187.5M | ||
| Q2 24 | $48.0M | $349.9M | ||
| Q1 24 | $50.6M | — |
総負債AMNPLUS
| Q4 25 | $767.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
株主資本AMNPLUS
| Q4 25 | $642.1M | $1.1B | ||
| Q3 25 | $644.4M | $1.0B | ||
| Q2 25 | $607.6M | $1.0B | ||
| Q1 25 | $715.1M | — | ||
| Q4 24 | $706.6M | $962.3M | ||
| Q3 24 | $890.7M | $947.0M | ||
| Q2 24 | $876.9M | $921.9M | ||
| Q1 24 | $854.2M | — |
総資産AMNPLUS
| Q4 25 | $2.1B | $1.8B | ||
| Q3 25 | $2.1B | $1.8B | ||
| Q2 25 | $2.2B | $1.8B | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.4B | $1.8B | ||
| Q3 24 | $2.7B | $1.7B | ||
| Q2 24 | $2.8B | $1.7B | ||
| Q1 24 | $2.9B | — |
負債/資本比率AMNPLUS
| Q4 25 | 1.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $75.6M | $-87.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $67.6M | — |
| FCFマージンFCF / 売上 | 9.0% | — |
| 設備投資強度設備投資 / 売上 | 1.1% | — |
| キャッシュ転換率営業CF / 純利益 | — | -2.49× |
| 直近12ヶ月FCF直近4四半期 | $233.8M | — |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローAMNPLUS
| Q4 25 | $75.6M | $-87.4M | ||
| Q3 25 | $22.7M | $-34.8M | ||
| Q2 25 | $78.5M | $-99.0M | ||
| Q1 25 | $92.7M | — | ||
| Q4 24 | $72.8M | $65.7M | ||
| Q3 24 | $66.7M | $-21.6M | ||
| Q2 24 | $99.5M | $97.1M | ||
| Q1 24 | $81.4M | — |
フリーキャッシュフローAMNPLUS
| Q4 25 | $67.6M | — | ||
| Q3 25 | $14.8M | — | ||
| Q2 25 | $68.7M | — | ||
| Q1 25 | $82.7M | — | ||
| Q4 24 | $56.6M | — | ||
| Q3 24 | $47.4M | — | ||
| Q2 24 | $72.2M | — | ||
| Q1 24 | $63.2M | — |
FCFマージンAMNPLUS
| Q4 25 | 9.0% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 10.4% | — | ||
| Q1 25 | 12.0% | — | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | 9.8% | — | ||
| Q1 24 | 7.7% | — |
設備投資強度AMNPLUS
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | 2.2% | — |
キャッシュ転換率AMNPLUS
| Q4 25 | — | -2.49× | ||
| Q3 25 | 0.77× | -1.00× | ||
| Q2 25 | — | -2.63× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.72× | ||
| Q3 24 | 9.54× | -0.69× | ||
| Q2 24 | 6.13× | 3.55× | ||
| Q1 24 | 4.70× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
PLUS
| All Others Customer End Market | $107.0M | 17% |
| Technology Customer End Market | $89.4M | 15% |
| Health Care Customer End Market | $81.5M | 13% |
| Financial Services Customer End Market | $66.1M | 11% |
| Professional Services Reporting Unit | $64.1M | 10% |
| Security | $61.1M | 10% |
| State And Local Government And Educational Institutions | $59.9M | 10% |
| Managed Services Reporting Unit | $48.8M | 8% |
| Other Product | $21.1M | 3% |
| Collaboration | $13.4M | 2% |
